advertisement
Cioffi GA 27
Showing records 1 to 25 | Display all abstracts from Cioffi GA95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Hark LA
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Dar S; De Moraes CG
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Kresch YS; De Moraes CG
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Karani R
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Horowitz JD
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Khan S; Chen R
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Park L
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Blumberg D
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Auran JD
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Harizman N
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Gorroochurn P
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Krawitz B
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Stempel S; Maruri SC
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Valenzuela IA
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Stidham EM
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Aliancy J; Tezel T
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Banks AZ
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Horowitz J
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Saaddine JB
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Bearelly S
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Lambert BC; Pizzi LT
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Coleman DJ
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Sapru S
Journal of Glaucoma 2021; 30: 388-394
94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Chang S
Journal of Glaucoma 2021; 30: 750-757
95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Price S
Journal of Glaucoma 2021; 30: 388-394
